Pharma & Biotech

Following prominent presentations at recent major healthcare conferences, the clinical progress of Olema Pharmaceuticals has captured significant market attention. The...

Investors in Spero Therapeutics are bracing for a pivotal period, with two key events poised to shape the biopharmaceutical company's...

The dissolution of InVivo Therapeutics Holdings is now in its concluding phase. The company’s operations, along with all its research...

The stock of Greenwich Lifesciences Inc finds itself in a holding pattern. In the absence of concrete news regarding fresh...

The coming weeks represent a critical juncture for Replimune Group Inc., with a key regulatory decision and a series of...

Engene's management team is preparing for a critical series of presentations that will place its clinical development program under the...

Recent financial disclosures from leading companies have prompted a strategic shift across the medical technology sector. The focus is now...

The specialized field of neurology is undergoing a significant transformation, driven by the convergence of digital health and artificial intelligence....

The biotechnology sector has proven to be a volatile landscape in early March 2026, shaped by evolving regulations and company-specific...

Blinklab is entering a pivotal operational phase as it scales up clinical validation efforts for its AI-driven autism diagnostic assistant....